← Leaderboards
Michael Mont
Johns Hopkins University
$690,436
Attributed
$2,071,309
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $822K · FY2019–24$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,071,309 · 2
By mechanism
U01$1,601,083 · 1
R34$470,226 · 1
Top collaborators
- Stuart B Goodman4 shared
- Lynne C. Jones4 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Mehran Armand$9,641,501
- David D. Celentano$57,488,358
- Jennifer A Haythornthwaite$14,995,955
- Melissa L Walls$12,401,095
- Neil A Goldenberg$4,077,863
Others in their field
Other Emerging Leaders on “Elements”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$60,854,952
- Yunda Huang · Fred Hutchinson Cancer Center$52,003,716
- Dwayne Forquer · Leidos Biomedical Research, Inc.$50,844,487
- Jean Macdonald · Dana-Farber Cancer Inst$26,990,229
- Kathleen Maletic Neuzil · Emory University$26,258,144
- Anthony Philippakis · University Of California Santa Cruz$21,943,238
Research focus
ElementsHip Region StructureConsensusEarly TreatmentHarvestHip JointClinical/RadiologicCommon TreatmentDesignBiologyEnd Stage DiseaseGrantBoneAutologousCessation Of LifeCharacteristicsBone NecrosisClinical TrialsArthritisCase SeriesCellsCell TherapyBiometryHip Replacement Arthroplasty
Grant awards (4)
Autologous Bone Marrow Aspirate Concentrate for the Treatment of Osteonecrosis of the Femoral Head$822,027
U01 · FY2024 · AR
Autologous Bone Marrow Aspirate Concentrate for the Treatment of Osteonecrosis of the Femoral Head$779,056
U01 · FY2023 · AR
Cell-Based Autogenous Grafting for the Treatment of Femoral Head Osteonecrosis$218,378
R34 · FY2020 · AR
Cell-Based Autogenous Grafting for the Treatment of Femoral Head Osteonecrosis$251,848
R34 · FY2019 · AR